TH176997A - CD44v6-derived cyclic peptide for the treatment of cancer and related diseases. With the creation of new blood vessels - Google Patents
CD44v6-derived cyclic peptide for the treatment of cancer and related diseases. With the creation of new blood vesselsInfo
- Publication number
- TH176997A TH176997A TH1701003077A TH1701003077A TH176997A TH 176997 A TH176997 A TH 176997A TH 1701003077 A TH1701003077 A TH 1701003077A TH 1701003077 A TH1701003077 A TH 1701003077A TH 176997 A TH176997 A TH 176997A
- Authority
- TH
- Thailand
- Prior art keywords
- cd44v6
- cancer
- creation
- treatment
- cyclic peptide
- Prior art date
Links
- 102000001189 Cyclic Peptides Human genes 0.000 title claims 2
- 108010069514 Cyclic Peptides Proteins 0.000 title claims 2
- 210000004204 Blood Vessels Anatomy 0.000 title 1
- 108010058905 CD44v6 antigen Proteins 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 150000001413 amino acids Chemical class 0.000 claims 4
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
Claims (1)
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TH176997B TH176997B (en) | 2018-06-14 |
| TH176997A true TH176997A (en) | 2018-06-14 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112018011073A2 (en) | anti-myostatin antibodies, polypeptides containing variant regions and methods of use | |
| EA201792651A1 (en) | Adenoviral polynucleotides and polypeptides | |
| JP2013172734A5 (en) | ||
| JP2014132019A5 (en) | ||
| WO2017025179A8 (en) | A transglutamine tag for efficient site-specific bioconjugation | |
| BR112018013246A2 (en) | peptide label and labeled protein including the same | |
| BR112016026842A2 (en) | preparation comprising factor viii and von willebrand factor peptides | |
| CL2017000200A1 (en) | Enhanced host cell to produce proteins | |
| BR112014028130A2 (en) | HYDROchloride salt of a peptide, pharmaceutical composition, use of a hydrochloride salt, use of a pharmaceutical composition, and method of preventing or treating cat allergy | |
| WO2015043566A8 (en) | Cyclic amyloid-beta-binding peptides and the use thereof | |
| DK3429577T3 (en) | N-LIPOINAMINO ACID OR PEPTIDE, DERIVATIVES AND USES THEREOF | |
| WO2016036635A8 (en) | Chromobacterium subtsugae genes | |
| TH176997A (en) | CD44v6-derived cyclic peptide for the treatment of cancer and related diseases. With the creation of new blood vessels | |
| WO2015077506A3 (en) | Identification of a novel b cell cytokine | |
| TH176997B (en) | CD44v6-derived cyclic peptide for the treatment of cancer and related diseases. With the creation of new blood vessels | |
| JP2015129652A5 (en) | ||
| WO2015041924A3 (en) | Recombinant respiratory syncytial virus (rsv) and caccines | |
| EA201990255A1 (en) | Blood clotting factor VII prolonged action and methods for its production | |
| TH1701002952A (en) | Stable derivative of conjugated ascorbic acid peptide. Method of preparation of such substances And substances in cosmetics that contain such substances | |
| TH177311A (en) | Protein fusion | |
| TH168459B (en) | New compound for the treatment of severe hypoglycemia | |
| TH168459A (en) | New compound for the treatment of severe hypoglycemia | |
| TH179026A (en) | New immunosuppressive therapies against many tumors, including lung cancer, including NSCLC. | |
| TH1701005732A (en) | New and holistic peptide and skeletal peptides for use in immunotherapy, anti-cancer of the kidney tissue (RCC) and other cancers. | |
| BR112017007816A2 (en) | pharmaceutical compositions comprising peptide variants and methods of using them |